Diet's impact on Alzheimer's dementia tested

February 18, 2014 by Thijs Westerbeek,
Diet's impact on Alzheimer's dementia tested
Credit: Ulrich Joho

A cocktail of ingredients containing omega-3 fatty acid found in fish oil is being tested in patients with mild cognitive impairment as a means to slow the progression of Alzheimer's dementia down

Scientists have long known that high levels of cholesterol around mid-life greatly increase the risk of developing dementia 30 years later. Cholesterol boosts the production of so-called beta amyloid peptides, which are the main component of the amyloid plaques found in the brains of Alzheimer patient. However, it is unclear as to whether changing the diet could prevent dementia. Or even whether the most beneficial and effective ingredients can be delivered in a pill or a small yoghurt drink. This is precisely the questions that the EU-funded LipiDiDiet study is focusing on.

The project follows on from previous efforts to identify beneficial types of fat, also called lipids, which could be of interest for treating dementia. "In an earlier project called LipiDiet— [by contrast to the current] LipiDiDiet project—hundreds of lipids were screened to find out whether they could be beneficial," says Tobias Hartmann, a professor of experimental neurology at the Saarland University in Homburg, Germany, who is also the LipiDiDiet project coordinator. The previous project identified several so-called 'bad' lipids, which had a negative effect, and a few which had just the opposite effect. "The best one from a practical point of view, [which] had to be digestible and non-toxic in amounts high enough to be effective, was an omega-3 fatty acid, [called] DHA, more commonly known as the of ," Hartmann tells CommNet.

But there is no consensus on whether DHA has a beneficial effect on the development of Alzheimer's disease. "In my research, I haven't seen any effect," says Ondine van de Rest, a researcher at the division for human nutrition from Wageningen University and Research Centre, in the Netherlands. Her PhD thesis focused on the effect of high dose on cognitive performance in patients with . Her research is not the only one that casts a doubt over the protective properties of fish oil. A large intervention study by US scientists came up with the same findings.

However, van de Rest's work was restricted to studying the effect of DHA as a single active ingredient. She believes it is still quite possible that DHA will work when combined with other lipids, namely precursors of lipids, and minerals. "It's a known fact that diet has a profound effect on cognitive development, it stands to reason that the same goes for the period in life when cognition deteriorates, old age," van de Rest tells CommNet, adding: "if there is a protection mechanism it's probably dependent on many components."

Previous research, according to Hartmann, did show a positive effect of DHA in the petri dish, in genetically modified Alzheimer mice as well as having a small positive effect on patients, who are at an early stage of dementia, treated with DHA in a combination with several other components such as EPA (eicosapentaenoic acid) and selenium. The latter approach suggests that earlier treatment would block the development of Alzheimer's before the damage is irreparable. Therefore, the project scientists felt more research was necessary.

This time, they tested the same mixture in patients who have slight memory loss, but are not suffering from Alzheimer's dementia yet. By the time the project is due to draw to a close, in March 2015, the team hopes to know whether this combination is able to prevent dementia or reduce the progression towards dementia. "Let's wait and see," says Hartmann.

Can this research finally give a definite answer? Some experts believe so. "I do believe it can," says Manfred Windisch, CEO of consultancy NeuroScios, in Graz, Austria, which specialises in drug development in neuroscience indications. "This is the first large international study wherein the fundamental science is translated into a big clinical trial," he adds. Windisch also notes that it is the first time test subjects are selected according to new criteria, like the fact that they suffer from slight memory loss, or mild , but not yet Alzheimer's . And they take the supplement over an extended period of time.

Explore further: Pinpointing the connection between diet and dementia

Related Stories

Pinpointing the connection between diet and dementia

November 22, 2013
Alzheimer's disease is a degenerative disorder affecting between 50 percent and 70 percent of all dementia sufferers. As neurons are killed slowly yet progressively, sufferers experience memory loss and confusion, which worsens ...

Dietary treatment shows potential in a mouse model of Alzheimer's disease

January 24, 2014
New research findings indicate that an early onset of dietary treatment may slow down the progression of Alzheimer's disease. The study was conducted on mice, and the results will be published in the February issue of Journal ...

Impaired recovery from inflammation linked to Alzheimer's disease

February 14, 2014
(Medical Xpress)—New research from Karolinska Institutet shows that the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer's disease. A study published in the journal Alzheimer's ...

Omega-3 dietary supplements pass the blood-brain barrier

December 4, 2013
(Medical Xpress)—New research from Karolinska Institutet shows that omega-3 fatty acids in dietary supplements can cross the blood brain barrier in people with Alzheimer's disease, affecting known markers for both the disease ...

Study suggests fish oil could help protect alcohol abusers from dementia

September 8, 2013
A Loyola University Chicago Stritch School of Medicine study suggests that omega-3 fish oil might help protect against alcohol-related dementia.

Recommended for you

New study highlights Alzheimer's herpes link, experts say

July 12, 2018
A new commentary by scientists at the Universities of Manchester and Edinburgh on a study by Taiwanese epidemiologists supports the viability of a potential way to reduce the risk of Alzheimer's disease.

Practice imperfect—repeated cognitive testing can obscure early signs of dementia

July 12, 2018
Alzheimer's disease (AD) is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

The 'Big Bang' of Alzheimer's: Scientists ID genesis of disease, focus efforts on shape-shifting tau

July 10, 2018
Scientists have discovered a "Big Bang" of Alzheimer's disease – the precise point at which a healthy protein becomes toxic but has not yet formed deadly tangles in the brain.

'Skinny fat' in older adults may predict dementia, Alzheimer's risk

July 5, 2018
A new study has found that "skinny fat—the combination of low muscle mass and strength in the context of high fat mass—may be an important predictor of cognitive performance in older adults. While sarcopenia, the loss ...

Pathway of Alzheimer's degeneration discovered

July 5, 2018
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University have used a unique approach to track brain degeneration in Alzheimer's disease, uncovering a pathway through which degeneration ...

Brain study paves way for therapy for common cause of dementia

July 4, 2018
Scientists have uncovered a potential approach to treat one of the commonest causes of dementia and stroke in older people.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.